Plasma derivative replacement therapy in diss. intravasc.coag.(DIC) induced by septic disorders with highly elevated elastase alpha 1AT-complexes.
暂无分享,去创建一个
R. Seitz | K. Havemann | M. Wolf | R. Egbring | H. Blanke | G. Fuchs | L. Lerch
[1] Disease,et al. Proteases II. Potential role in health and disease. Proceedings of the second international conference. May 17-20, 1987, Rothenburg, Federal Republic of Germany. , 2012, Advances in experimental medicine and biology.
[2] R. Seitz,et al. The proteinase inhibitor complexes (antithrombin III-thrombin, alpha 2antiplasmin-plasmin and alpha 1antitrypsin-elastase) in septicemia, fulminant hepatic failure and cardiac shock: value for diagnosis and therapy control in DIC/F syndrome. , 1986, Behring Institute Mitteilungen.
[3] E. B. Reeve,et al. Steady state relations between factors X, Xa, II, IIa, antithrombin III and alpha-2 macroglobulin in thrombosis. , 1980, Thrombosis research.
[4] K. Havemann,et al. Demonstration of granulocytic proteases in plasma of patients with acute leukemia and septicemia with coagulation defects. , 1977, Blood.
[5] K. Havemann,et al. Physiology and pathophysiology of neutral proteinases of human granulocytes. , 1984, Advances in experimental medicine and biology.